The link between type 2 diabetes and dementia: from biomarkers to treatment

Affiliations

¹ Department of Psychiatry, Ichan School of Medicine at Mount Sinai, New York, NY 10029, USA; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel-Hashomer, Israel. Electronic address: michal.beeri@mssm.edu.
² Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

Comment

Michal Schnaider Beeri et al. Lancet Diabetes Endocrinol. 2020 Sep.

. 2020 Sep;8(9):736-738.

doi: 10.1016/S2213-8587(20)30267-9. Epub 2020 Jul 30.

¹ Department of Psychiatry, Ichan School of Medicine at Mount Sinai, New York, NY 10029, USA; The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel-Hashomer, Israel. Electronic address: michal.beeri@mssm.edu.
² Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

No abstract available

Comment on

Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective.
Biessels GJ, Nobili F, Teunissen CE, Simó R, Scheltens P. Biessels GJ, et al. Lancet Neurol. 2020 Aug;19(8):699-710. doi: 10.1016/S1474-4422(20)30139-3. Epub 2020 May 20. Lancet Neurol. 2020. PMID: 32445622 Review.
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches.
Kellar D, Craft S. Kellar D, et al. Lancet Neurol. 2020 Sep;19(9):758-766. doi: 10.1016/S1474-4422(20)30231-3. Epub 2020 Jul 27. Lancet Neurol. 2020. PMID: 32730766 Free PMC article. Review.